Skip to content

Treatment of M.Graves With Radioactive Iodine: Follow-up Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00525122
Enrollment
100
Registered
2007-09-05
Start date
2007-09-30
Completion date
Unknown
Last updated
2008-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism

Keywords

hyperthyroidism, radioactive iodine, antithyroid drugs, Hyperthyroidism, treatment with radioactive iodine without antithyroid drugs

Brief summary

Hypothesis: What is the natural course after treatment with radioactive iodine in patients with hyperthyroidism? What are the determinants for the development of acute hypo- or hyperthyroidism after treatment with radioactive iodine without antithyroid drugs?

Interventions

None listed

Sponsors

Medisch Centrum Rijnmond-Zuid, Netherlands
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients wth hyperthyroidism who are eligible for treatment with radioactive iodine * Age \> 18 years

Exclusion criteria

* Severe ophthalmopathy * Pregnancy or wish to pregnancy on short term * Breastfeeding * Patients already treated with radioactive iodine * Known cardiovascular diseases or other severe comorbidity

Countries

Netherlands

Contacts

Primary ContactA. Berghout, MD, PhD
BerghoutA@mcrz.nl0031 10 2913368

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026